Fact CheckerSign in

NCT06686303Completed

Effects of Combined Segmental Vibrator and Neuromuscular Electrical Stimulation in Subacute Stroke

Combined Effects of Segmental Vibrator With Neuromuscular Electrical Stimulation for Flexor and Extensor Muscle Groups on Upper Limb Function in Sub Acute Stroke

Source: ClinicalTrials.gov · Last updated 9 Apr 2025

Brief summary (registry, in English)

Stroke is leading cause of death and disability worldwide, resulting in significant functional limitations and disabilities experienced by stroke survivors, particularly in the upper limb. There is a need for more effective interventions targeting upper limb sensory motor impairments. The aim of this study is to study combined effect of segmental vibrator and neuromuscular electrical stimulation for flexor and extensor muscle groups on upper limb function in sub-acute stroke.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
12 Nov 2024
Start date
1 Jan 2024
Primary completion date
5 Dec 2024
Lead sponsor
Riphah International University
Diseases
Stroke
NCT number
NCT06686303

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 1 Jan 2024 to the primary completion date, 5 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of other neurological diseases,rheumatic and orthopaedic conditions
  • Patients under anti-spastic therapy or other clinical trials

Other illness

  • Psychiatric disease and cognitive impairment
  • Metal implants e.g. cardiac pacemakers

Other

  • Patients with bilateral brain lesions
  • Ischemic involvement of cerebellum or basal ganglia

Who the study is looking for

  • Patients of both genders
  • Aged between 45 and 65 years old
  • First ever ischemic stroke experienced more than 3 months before the enrollment
  • Spasticity of spastic agonist muscles ranging from 0-2 on the MAS

Age in the registry: 45 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Bone and Joint Hospital
Coordinator of this site? Confirm its status
SialkotPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.